Clinical Trial Update: A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic Patients [Phase 1]

View source ↗

Summary

This Phase 1 trial reports the safety and tolerability results for a single oral dose of AZD6370 (P-Glucose) in adults with Type 2 diabetes mellitus, completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• P-Glucose (AZD6370)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED